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n 1997, in an effort to improve 
the pursuit of virology in the state 
of São Paulo, Brazil, a group of 
scientists proposed the establishment 
of a Viral Genetic Diversity Network 
(VGDN) to São Paulo’s major scientiﬁc 
funding agency, Fundação de Amparo 
à Pesquisa do Estado de São Paulo 
(FAPESP). The major impetus for the 
project was the earlier establishment 
of the Xylella fastidiosa genome
sequencing consortium [1], organised 
to counter this plant pathogen, which 
has had a serious impact on the 
Brazilian agricultural economy and 
industry. In addition to addressing 
this important national priority, the 
X. fastidiosa sequencing consortium 
also had a major qualitative impact 
on genome sciences in Brazil. Taking 
inspiration from the success of the 
genome sequencing effort, the VGDN 
envisaged a network of laboratories at 
several research institutions in the state 
of São Paulo, with the aim of studying 
key viral diseases within an applied 
context. Its main goal was to provide 
competence in genetic studies of 
viruses and to acquire primary data of 
immediate use (e.g., the monitoring of 
vaccines, antiviral drug resistance, and 
the spread of speciﬁc viral genotypes). 
The VGDN proposal was evaluated by 
a panel of top international scientists 
and eventually approved for funding by 
FAPESP.
Under the concept of a “virtual 
institute” fostered by FAPESP [2], the 
programme was organised as a multi-
centre, multi-task network comprising 
ﬁve central laboratories and 17 
satellite units, strategically distributed 
throughout the state. Although 
member institutions were encouraged 
to pursue their own independent 
lines of research, all had to cooperate 
on four viruses of particular public 
health importance for Brazil: HIV-1, 
hepatitis C virus, human respiratory 
syncytial virus (HRSV), and hantavirus. 
The unifying elements of the VGDN 
included: (1) a system of sampling and 
experimental design utilising clinical 
and epidemiological information; 
(2) large-scale automated viral gene 
sequencing; and (3) the tracking 
of genetic variants during epidemic 
outbreaks to detect variants of 
importance for diagnosis and vaccines. 
A core set of VGDN laboratories 
started operations in 2001, conducting 
a pilot study on HIV-1 together 
with state-run sexually transmitted 
disease/AIDS reference centres at a 
total cost of US$2 million. Over the 
next few years, FAPESP invested a 
total of US$7.5 million in the VGDN. 
Crucially, the infrastructure, technical 
capabilities, and some research time 
provided under the VGDN were 
also utilised by each participating 
member as seed for the establishment 
of research projects beyond the four 
coordinated tasks. The VGDN had 41 
researchers, the direct involvement of 
115 graduate and 29 under-graduate 
students, and 69 technicians. Almost 
all of the institutions provided funds 
in addition to the resources included 
under the programme, and in three 
campuses across the state, new virology 
units (including new buildings) were 
established. A total of 20 laboratories 
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Figure 1. The Number of Virology Publications, Documented on PubMed, from 1992–2006 
for the States of São Paulo and Rio de Janeiro, Brazil
A major increase in publication numbers was observed in São Paulo following the onset of VGDN 
funding in 2001.
The Community Page is a forum for organizations 
and societies to highlight their efforts to enhance the 
dissemination and value of scientiﬁc knowledge.PLoS Biology  |  www.plosbiology.org PLoS Biology  |  www.plosbiology.org 0429 March 2008  |  Volume 6  |  Issue 3  |  e57
(seven of which are biosafety level 3) 
were either newly built, renovated, or 
re-equipped.
The large amount of basic virological 
data resulting from each coordinated 
task has already been passed on to 
the public health system, and is being 
prepared for publication. The HIV-1 
coordinated task has generated 20% 
of the viral genome, coupled with 495 
pieces of socio-economic and clinical 
data from each of the 1,279 geo-
referenced patients from eight cities 
within the state of São Paulo sampled 
between 2001 and 2004. These data are 
currently being used for an intensive 
study of the patterns of dispersal of 
subtypes and circulating recombinants 
of HIV-1, as well as of resistance 
patterns relating to treatment outcome. 
As the Brazilian government spends 
US$731 million annually on free drug 
treatment and clinical follow-up for 
HIV-1 carriers, these unique data allow 
an in-depth assessment of the success 
of this important health programme, 
particularly in the face of considerable 
friction among pharmaceutical 
companies and the government on 
issues of drug prices and patents. 
Similarly, the hepatitis C virus 
coordinated task involves the study 
of 1,000 patients undergoing anti-
viral therapy in three cities. The data 
produced as part of this project have 
provided vital information on the 
role of blood donation policies in 
the dispersal of viral genotypes over 
the last 20 years. Since 2005, a total 
of 2,000 samples have been collected 
for the HRSV coordinated task, 
which, combined with retrospectively 
sampled sequence data, has provided 
a unique insight into the intricate 
ﬂuctuating dynamics of HRSV-
type genotypes A and B. Finally, 
hantavirus pulmonary syndrome is an 
increasing health problem in Brazil 
(884 cases were reported in 2007, 
with a 39% case fatality rate [3]), due 
to the encroachment of urban and 
agricultural land use on the habitats 
of the rodents who serve as reservoirs 
for the virus. With the data collected 
under the hantavirus coordinated task, 
researchers are studying the association 
of human cases with speciﬁc viral 
lineages.
In addition to all of these direct 
beneﬁts accrued from the operation 
of the VGDN, the indirect impact on 
the net scientiﬁc output in the state 
of São Paulo has been extensive. This 
is evident from PubMed searches for 
publications by virologists based in 
São Paulo state. A remarkable change 
in the annual rate of publishing 
was observed from 2001 onwards 
(Figure 1). As a comparison, we also 
plotted the equivalent data from the 
neighbouring state of Rio de Janeiro, 
which harbours the largest community 
of virologists in Brazil. The slopes 
of the lines on the graph up to 2001 
are indistinguishable. However, after 
2001, the publication rate in São Paulo 
showed a considerable increase, which 
can be attributed to an overall boost in 
virological expertise due to the VGDN. 
A similar growth was also observed 
for biomedical sciences in São Paulo, 
although no VGDN groups directly 
invested resources in these efforts.
It is clear that the VGDN has been 
pivotal in establishing a more efﬁcient 
infrastructure for the surveillance 
and monitoring of emerging and re-
emerging viral diseases in São Paulo 
state, using modern techniques and 
facilities and bringing public health 
experts and academic researchers 
together under the same virtual roof. 
We believe that this unique initiative 
may constitute a viable model for other 
developing countries, not only to help 
alleviate the risk of pandemics, but also 
to facilitate and support basic scientiﬁc 
research.  
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